Yes weight regain after stopping is well-documented for both drugs
GLP-1 medications may be appropriate for: Individuals who are overweight or obese Patients with Type 2 diabetes Those with weight-related health conditions Patients who have not had success with diet and exercise alone These medications must be prescribed and monitored by a qualified provider
(PubMed) Ho MJ, Li EC, Wright JM
Tracking Progress with Shotlee For individuals embarking on a weight loss journey with advanced therapies, meticulous tracking of progress, symptoms, and medication adherence is essential
The FDA has only approved six weight loss drugs, including: Bupropion-naltrexone (Contrave) Liraglutide (Saxenda) Orlistat (Xenical, Alli) Phentermine-topiramate (Qsymia) Semaglutide (Wegovy) Setmelanotide (Imcivree) Currently, the choice of weight loss drugs remains very limited and is divided into two main categories: pancreatic lipase inhibitors and appetite suppressants that act on the central nervous system